HCPLive Network
Latest Oncology Headlines
For patients undergoing radiotherapy, shared decision-making and patient-perceived control in treatment decisions correlate with increased patient satisfaction, according to a study published online March 19 in Cancer.
Poor kidney function, measured by a low glomerular filtration rate, is independently associated with a higher risk of incident cancer, compared to participants with preserved GFR, according to a study presented at the National Kidney Foundation's 2014 Spring Clinical Meetings, held from April 22 to 26 in Las Vegas.
By Silas Inman
The FDA has approved the cobas HPV Test as a first-line screening tool for cervical cancer in women 25 and older, making it the first-ever approval for a diagnostic alternative to Pap smear.
The presence of chronic inflammation in benign prostate tissue samples is associated with prostate cancer, especially high-grade disease, according to a study published online April 18 in Cancer Epidemiology, Biomarkers & Prevention.
Changes in medical education and training are suggested to help new physicians address the needs of patients and their families, according to an ideas and opinions piece published in the April 22 issue of the Annals of Internal Medicine.
The US Food and Drug Administration has proposed a new program to provide earlier access to high-risk medical devices intended to treat or diagnose patients with serious conditions whose medical needs are not met by current technology.
By Kristin Higgins, MD
Locally advanced non-small cell lung cancer (NSCLC) remains a challenging disease to treat, with a 5-year survival rate for patients with unresectable stage III disease of approximately 20%, even after definitive radiation therapy and concurrent chemotherapy.
By Silas Inman
The FDA has approved the anti-IL-6 chimeric monoclonal antibody siltuximab as a treatment for HIV- and HHV-8-negative patients with multicentric Castleman’s disease.
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.
A methylation-specific 10-gene panel can detect advanced breast cancer and reflects chemotherapy response, according to a study published in the April 15 issue of Cancer Research.
False-positive mammogram results are tied to increased short-term, but not long-term, anxiety, according to a study published online April 21 in JAMA Internal Medicine.
By Andrew J. Roth
A novel immunotherapeutic known as IMCgp100 induced clinical responses with manageable toxicity in patients with advanced melanoma
Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18, according to a study published in the May issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.
By Anita Shaffer
Although the potential for next-generation sequencing of breast cancer tumors to improve treatment strategies is widely recognized, questions swirl about the optimal use of such increasingly available technologies in clinical practice for today’s patients.
By Silas Inman
GSK and Novartis have struck a deal that will move all of GSK's oncology assets to Novartis, all of Novartis' non-flu-related vaccines to GSK, and will result in a joint consumer healthcare venture.
By Christina Izzo
A 10-year follow-up study of regional melanoma staging strategies found that patients who underwent sentinel-node biopsies had significantly greater disease-free survival rates (DFSRs) compared with patients monitored through nodal observation.
By Silas Inman
The FDA has approved the VEGFR-2 inhibitor ramucirumab as a treatment for patients with patients with unresectable gastric cancer or gastroesophageal junction adenocarcinoma, based on a significant extension in OS.
By Andre Goy, MD
Medicine is undergoing a revolution that will transform the practice of healthcare, including oncology.
By Anita Shaffer
A wide-ranging analysis of more than 5500 breast cancer tumors that combined genomic and protein expression testing has identified promising targets to explore for treating patients with poor prognoses, with particularly notable findings involving androgen receptor (AR) expression
By Frank J. Domino, MD
It is worrisome that "high-impact" data read by most healthcare providers and then further interpreted and distributed by lay news organizations may have funder bias.
Physician's Money Digest
State income taxes can be confusing. While some states have no income tax at all, others have multiple brackets. Does your state have one of the highest top income tax rates?
The business of catering to vices is doing well and the portfolios of people invested in tobacco, gaming, and alcohol stocks are benefiting.
$AD300x250BB$